CNBC Special Report: How Soaring U.S. Drug Prices Fueled What Feds Call An Illegal Import Of Medications 11/27/25
A CNBC investigation examines how high U.S. drug prices have led to the rise of alternative funding programs (AFPs) that import medications. The report includes perspectives from U.S. health officials regarding the legality and safety risks of these programs.